WallStSmart
ALDX

Aldeyra The

NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY

$1.52
+1.33% today

Updated 2026-04-30

Market cap
$90.48M
P/E ratio
P/S ratio
EPS (TTM)
$-0.56
Dividend yield
52W range
$1 – $6
Volume
3.6M

Aldeyra The (ALDX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201120122013201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$18778.00$35792.00$37849.00$71003.00$96305.00$56221.00$264180.00$258707.00$262780.00$249623.00$251993.00
Gross profit$0.00$-18778.00$-35792.00$-37849.00$-71003.00$-96305.00$-56221.00$-264180.00$-258707.00$-262780.00$-249623.00$-251993.00
Gross margin
R&D$1.36M$469270.00$1.54M$3.71M$7.57M$13.18M$16.30M$29.82M$44.35M$24.68M$44.94M$47.31M$29.46M$48.22M$25.66T
SG&A$743941.00$644941.00$2.13M$3.56M$4.42M$5.52M$6.19M$9.88M$12.15M$9.98M$11.28M$15.37M$13.34M$11.89M$9.60T
Operating income$-2.11M$-1.11M$-3.68M$-7.27M$-11.99M$-18.70M$-22.49M$-39.70M$-63.07M$-34.67M$-56.22M$-62.68M$-42.79M$-60.12M$-35.27M
Operating margin
EBITDA$-2.10M$-22.73M$13.22M$-4.94M$-11.96M$-18.56M$-22.19M$-38.67M$-61.44M$-36.07M$-55.77M$-60.07M$-35.21M$-53.68M$-31.69M
EBITDA margin
EBIT$-2.10M$-22.73M$13.22M$-4.94M$-11.98M$-18.59M$-22.23M$-38.75M$-61.53M$-36.13M$-56.03M$-60.33M$-35.47M$-53.93M$-31.94M
Interest expense$279932.00$342014.00$159323.00$244174.00$112306.00$105509.00$113454.00$146792.00$603846.00$1.90M$1.74M$1.69M$2.07M$1.93M$1.91M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.38M$-23.07M$13.06M$-5.19M$-12.09M$-18.70M$-22.34M$-38.89M$-60.83M$-37.55M$-57.78M$-62.02M$-37.54M$-55.85M$-33.85M
Net income growth (YoY)-870.4%+156.6%-139.7%-133.1%-54.7%-19.5%-74.1%-56.4%+38.3%-53.8%-7.4%+39.5%-48.8%+39.4%
Profit margin